Drug
Ion904
Ion904: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ION904 NCT05314439 | Phase 2 | Hypertension |
| ION904 NCT04731623 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Ion904 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.